Singapore HSA Updates GN-06: Guidance on Distribution Records for Medical Devices

HSA has included “ISO 13485:2016” in defining the projected useful life of a medical device. Product owners may refer to …

read more...

Singapore HSA Updates Medical Device Guidance GN-20: Guidance on Clinical Evaluation

HSA has specified “ISO 14155 – Clinical Investigation of Medical Devices for Human Subjects” in GN-20: Guidance on Clinical Evaluation, …

read more...

Singapore HSA Publishes New Regulatory Guidelines for Laboratory Developed Tests (LDTs)

Laboratory Developed Tests (LDTs) are in vitro diagnostic tests (IVDs) that are: • developed and manufactured within a licensed clinical …

read more...

Philippines FDA Publishes Circular on The Abridged Processing of Medical Devices Registration With Approval by The NRA of Any ASEAN Member Country

Philippines FDA issues Circular No. 2022-008 on 27th September 2022, aims to provide guidelines on the abridged processing of applications …

read more...

China NMPA Extends Drug Submission Time for Supplementing Materials

On October 14th, China’s National Medical Products Administration (NMPA) announced an extra 80 to 160 days extension for the submission …

read more...

Hong Kong DOH Updates the List of Refence Countries for Registration of Pharmaceutical Products

Hong Kong’s Pharmacy and Poisons Board reviewed the requirements of the list of reference countries for the registration of pharmaceutical …

read more...

Thailand FDA Implements GMP Clearance Temporary Process During COVID-19 Pandemic

The State Drug Regulatory Authorities overseas, responsible for the assessment of manufacturing standards according to GMP principle, have postponed the …

read more...

Singapore HSA to Commence Phase 1 Implementation of Unique Device Identification (UDI) System

From 1st November 2022, all medical devices under the closed list of high-risk implantable published in HSA’s guidance document GN-36: …

read more...

Vietnam Ministry of Health Updates Guidance Report of Bioavailability/Bioequivalence for Drug Registration

This Circular is issued on 5 Sept 2022, effective on 1 Nov 2022, and replaced the current guideline Circular 08-2010/TT-BYT …

read more...